VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IONS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IONSIonis Pharmaceuticals, Inc.
$80.69$13.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIONSQuarterly Financials

Ionis Pharmaceuticals, Inc. (IONS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ionis Pharmaceuticals, Inc. (IONS) quarterly income statement — complete revenue, gross profit & net income history

IONS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue246.09M203M156.72M452.05M131.61M226.58M133.81M225.25M119.5M324.5M144.21M188.41M130.52M151.89M159.77M133.79M141.92M440.01M133.09M125.75M
Revenue Growth %86.98%-10.41%17.12%100.69%10.14%-30.18%-7.21%19.55%-8.45%113.65%-9.74%40.82%-8.03%-65.48%20.04%6.39%27.16%51.58%-16.86%-13.6%
Cost of Goods Sold2.98M8M2.34M4.15M1.5M3.83M1.07M4.16M2.15M3.06M2.19M2.54M1.34M3.69M1.51M4.75M4.17M2.23M3.08M2.96M
COGS % of Revenue1.21%3.94%1.49%0.92%1.14%1.69%0.8%1.85%1.8%0.94%1.52%1.35%1.03%2.43%0.95%3.55%2.94%0.51%2.31%2.35%
Gross Profit243.11M195M154.38M447.9M130.11M222.75M132.74M221.09M117.35M321.44M142.02M185.87M129.18M148.2M158.25M129.05M137.75M437.78M130.01M122.79M
Gross Margin %98.79%96.06%98.51%99.08%98.86%98.31%99.2%98.15%98.2%99.06%98.48%98.65%98.97%97.57%99.05%96.45%97.06%99.49%97.69%97.65%
Gross Profit Growth %86.85%-12.46%16.3%102.59%10.88%-30.7%-6.53%18.94%-9.16%116.89%-10.26%44.04%-6.22%-66.15%21.72%5.09%26.34%52.55%-17.18%-13.85%
Operating Expenses360.53M410M314.56M308.08M276.97M333.57M281.4M287.18M266.86M327.57M285.28M276.07M243.33M356.22M217.41M214.56M195.25M217.18M215.86M195.76M
OpEx % of Revenue146.5%201.97%200.72%68.15%210.45%147.22%210.29%127.49%223.32%100.94%197.83%146.52%186.42%234.53%136.08%160.37%137.58%49.36%162.19%155.67%
Selling, General & Admin150.36M130M96.8M90.6M76.3M88.1M61.6M65.1M52.64M71M70M46.14M45.52M47.9M34.4M33.8M34.13M38.6M30.1M45.1M
SG&A % of Revenue61.1%64.04%61.77%20.04%57.97%38.88%46.03%28.9%44.05%21.88%48.54%24.49%34.87%31.54%21.53%25.26%24.05%8.77%22.62%35.86%
Research & Development210.17M280M217.75M217.46M200.76M245.49M219.76M222.06M214.22M256.56M215M230M198M308M182.99M180.76M161.13M179M184.77M139.31M
R&D % of Revenue85.4%137.93%138.95%48.11%152.54%108.35%164.23%98.59%179.26%79.06%149.09%122.07%151.7%202.78%114.54%135.1%113.53%40.68%138.83%110.78%
Other Operating Expenses009K22K-87K-21K38K13K011K-49K0050K16K2K0-1000K993K1000K
Operating Income-117.42M-215M-160.18M139.82M-146.86M-110.82M-148.66M-66.09M-149.51M-6.12M-143.26M-90.19M-114.15M-208.02M-59.15M-85.51M-57.5M220.6M-85.85M-72.97M
Operating Margin %-47.72%-105.91%-102.21%30.93%-111.59%-48.91%-111.09%-29.34%-125.12%-1.89%-99.35%-47.87%-87.45%-136.95%-37.03%-63.92%-40.52%50.14%-64.5%-58.03%
Operating Income Growth %20.04%-94%-7.75%311.55%1.77%-1709.95%-3.76%26.72%-30.98%97.06%-142.19%-5.47%-98.5%-194.29%31.1%-17.19%37.48%1073.29%-134.96%-40.99%
EBITDA-117.42M4.6B-155.68M145.27M-141.46M-105.56M-143.16M-60.51M-143.86M-511K-137.67M-84.51M-108.54M-200.99M-54.06M-80.43M-52.61M225.59M-81.14M-67.95M
EBITDA Margin %-47.72%2267.23%-99.34%32.14%-107.48%-46.59%-106.99%-26.86%-120.39%-0.16%-95.47%-44.85%-83.16%-132.33%-33.84%-60.11%-37.07%51.27%-60.97%-54.04%
EBITDA Growth %16.99%4460.23%-8.74%340.07%1.67%-20556.75%-3.99%28.39%-32.54%99.75%-154.67%-5.07%-106.32%-189.1%33.38%-18.35%39.61%1346.28%-152.9%-42.39%
D&A (Non-Cash Add-back)04.82B4.5M5.45M5.4M5.27M5.49M5.58M5.65M5.61M5.59M5.69M5.61M7.03M5.09M5.09M4.89M4.98M4.71M5.01M
EBIT-118M-210M-107.84M144.78M-125.4M-85.77M-122.87M-43.41M-122.17M18.08M-120.43M-57.5M-97.12M-43.93M-45.91M-102.08M-63.25M222.1M-82.87M-79.55M
Net Interest Income-17M-18M1.52M1.93M1.74M6.05M3.53M2.81M4.17M3.28M1.95M846K1.5M10.15M5.38M1.27M-129K-430K-1.47M377K
Interest Income0023.68M24.69M24.67M28.91M26.23M25.6M26.29M25.69M23.93M20.79M18.63M11.88M7.52M3.4M1.99M1.81M872K2.73M
Interest Expense17M18M22.16M22.76M22.93M22.86M22.69M22.79M22.11M22.41M21.98M19.95M17.12M1.73M2.14M2.13M2.12M2.24M2.34M2.36M
Other Income/Expense25.11M-13M31.79M-16.29M38K3.78M4.55M-110K6.79M3.36M2.46M12.75M1.21M163.69M12.45M-17.36M-6.57M4.31M2.08M-7.58M
Pretax Income-92.31M-228M-128.39M123.53M-146.82M-107.04M-144.1M-66.2M-142.73M-2.77M-140.81M-77.45M-112.94M-44.33M-46.71M-102.88M-64.07M224.92M-83.77M-80.55M
Pretax Margin %-37.51%-112.32%-81.93%27.33%-111.56%-47.24%-107.69%-29.39%-119.44%-0.85%-97.64%-41.11%-86.53%-29.19%-29.24%-76.89%-45.15%51.12%-62.94%-64.05%
Income Tax218K1M213K-20K116K-2.69M-3.62M64K75K6.5M6.6M7.84M11.38M8.1M283K2.26M1.09M303K-1.31M327K
Effective Tax Rate %-0.24%-0.44%-0.17%-0.02%-0.08%2.51%2.51%-0.1%-0.05%-234.77%-4.69%-10.13%-10.08%-18.27%-0.61%-2.2%-1.71%0.13%1.56%-0.41%
Net Income-92.53M-229M-128.61M123.55M-146.94M-104.35M-140.48M-66.27M-142.8M-9.26M-147.41M-85.29M-124.32M-52.43M-46.99M-105.14M-65.17M224.61M-82.47M-80.88M
Net Margin %-37.6%-112.81%-82.06%27.33%-111.64%-46.05%-104.98%-29.42%-119.5%-2.85%-102.22%-45.27%-95.25%-34.52%-29.41%-78.58%-45.92%51.05%-61.96%-64.31%
Net Income Growth %37.03%-119.46%8.45%286.45%-2.9%-1026.51%4.7%22.31%-14.86%82.33%-213.69%18.88%-90.78%-123.34%43.02%-30%27.49%166.01%-237.05%-215.47%
Net Income (Continuing)-92.53M-229M-128.61M123.55M-146.94M-104.35M-140.48M-66.27M-142.8M-9.26M-147.41M-85.29M-124.32M-52.43M-46.99M-105.14M-65.17M224.61M-82.47M-80.88M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.56-1.41-0.800.68-0.93-0.66-0.95-0.45-0.98-0.06-1.03-0.59-0.87-0.37-0.33-0.74-0.461.41-0.58-0.57
EPS Growth %39.78%-113.64%15.79%251.11%5.1%-926.44%7.77%23.73%-12.64%82.62%-212.12%20.27%-89.13%-126.24%43.1%-29.82%28.13%158.02%-163.64%-147.83%
EPS (Basic)-0.56-1.41-0.800.78-0.93-0.66-0.95-0.45-0.98-0.06-1.03-0.59-0.87-0.37-0.33-0.74-0.461.59-0.58-0.57
Diluted Shares Outstanding164.87M162M160.76M182.33M158.74M158M148.59M145.96M145.54M144M143.32M143.1M142.74M142M141.95M141.79M141.6M160M141.14M140.96M
Basic Shares Outstanding164.87M162M160.76M159.14M158.74M158M148.59M145.96M145.54M144M143.32M143.1M142.74M142M141.95M141.79M141.6M141M141.14M140.96M
Dividend Payout Ratio--------------------